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Abstract
Increasing numbers of cystic fibrosis (CF) patients are surviving into adulthood. An understanding of the psychiatric and
psychosocial aspects of CF in adults and adolescents is therefore more important than ever. There is a large body of evidence
indicating that the psychological and psychosocial functioning of people with CF is similar to that of well people, until the
disease becomes severe. However, there is also evidence that patients do suffer an increased likelihood of psychiatric problems,
such as depression, and of scoring poorly on physical functioning measures of quality of life. Studies have found conflicting
evidence as to any association between degree of respiratory impairment and psychological functioning. Coping styles seem to
have a large effect upon the quality of life of CF patients. People with cystic fibrosis can have problems with sexuality, platonic
relationships and independence. Families of patients also suffer problems, which can affect the patients themselves. Non-
compliance is a complicated problem with many patients. New treatments for people with CF are emerging, such as lobe
transplants from live donors and gene therapy, with possible new psychosocial problems resulting. Furthermore, older studies are
becoming increasingly inapplicable as treatment and prognosis changes. Therefore, more research is needed in this field.
 2003 European Cystic Fibrosis Society. Published by Elsevier Science B.V. All rights reserved.
Keywords: Cystic Fibrosis; Psychology; Psychiatry; Compliance
1. Introduction
The prognosis of cystic fibrosis has changed dramat-
ically over the last 10 years or so with increasing
numbers of patients surviving into adulthood. It is
important not to overlook the psychosocial aspects of
this group of patients to ensure the quality of their
increased life is good. In order to do so, it is necessary
first of all to try and assess what level of psychosocial
problems are present and, as a first step, we have
reviewed the literature in this area. With the changing
prognosis many older psychosocial studies may no
longer be appropriate and we have therefore concentrat-
ed on more recent papers (from 1990 onwards).
2. Quality of life in people with Cystic Fibrosis
Although a corner stone of modern medicine, the
term ‘quality of life’ lacks a clear definition, but is often
taken as a measure of the impact of a disease on
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psychological, psychosocial and physical functioning.
Varying emphasis on these different aspects of function-
ing effects whether cystic fibrosis is found to lead to a
significantly worse quality of life (QOL) or not.
A number of studies have concentrated on the psycho-
social and psychiatric impact of cystic fibrosis. Anderson
et al. w1x found only some subclinically elevated levels
of psychopathology (hypochondriasis and hysteria on
Minnesota Multiphasic Personality Inventory –2) in
cystic fibrosis adults, though the prevalence of clinical
depression and anxiety was similar to the general pop-
ulation. However, the different analytical instruments
used in this study found conflicting evidence of which
factors may be associated with more serious psychopa-
thology. For example, male gender was found to predict
significantly higher levels of depression using one psy-
chological test (Beck Depression Index) but not another
(Minnesota Multiphasic Personality Inventory –2).
These conflicting results using different psychiatric
instruments question whether these tests are suitable for
accurately discerning the levels of psychopathology in
cystic fibrosis or may indicate that the levels of psycho-
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pathology are of borderline significance. The two instru-
ments do have slightly different focuses—the former
focusing on mood in the preceding 2 weeks and the
latter more on personality traits.
Pearson et al. w2x tested adults with cystic fibrosis
and found a prevalence of anxiety of 22.2% and depres-
sion of 42.4%. They found that the different indices of
psychiatric behaviour and global emotional difficulties
were intercorrelated. Blair et al. w3x found the psycho-
logical functioning of young adults with cystic fibrosis
to be in many ways similar to that of healthy young
people.
Shepherd et al. w4x and de Jong et al. w5x found that
the psychosocial functioning of CF patients did not
differ significantly from that of healthy control groups.
However, de Jong et al. w5x did find the cystic fibrosis
patients to have a significantly worse quality of life
reflecting their significantly impaired scores for physical
functioning. Shepherd et al. w4x found some differences
between CF patients and controls, particularly in the
area of undertaking life-style changes, and similarly,
Blair et al. w3x found that CF patients were less likely
to be in employment than subjects in the control group.
Congleton et al. w6x found that although patients with
cystic fibrosis were more likely to report problems in
areas of daily living than a normal population, their
QOL was generally similar to that of patients with minor
non-acute health conditions, not being nearly as impaired
as might be expected. Recently, Britto et al. w7x found
young adults with CF to have lower scores on several
measures of physical functioning and for general health
perception, but to have similar scores for most psycho-
social measures.
Therefore, on the whole, the evidence supports young
adult CF patients generally having a psychological
functioning similar to healthy controls. However, CF
does have a negative impact on physical functioning
aspects of quality of life. Nevertheless, a large proportion
of adults with CF are living full and productive lives
w8x.
3. Relation between clinical health and quality of life
An important question is whether there is a relation
between clinical health measures and quality of life.
This can be subdivided into whether clinical health
measures are predictive of QOL, whether acute changes
in clinical health are associated with changes in the
QOL and whether the QOL of patients changes over the
long-term as their health deteriorates.
There is conflicting evidence as to whether clinical
health measures are predictive of quality of life, though
there is little study of patients who are severely ill and
rapidly deteriorating. Anderson et al. w1x found no
significant differences in psychological functioning
between subgroups of patients based on lung function
or body weight, though a MANOVA statistical procedure
found better health status to predict lower scores of
psychological distress. Pearson et al. w2x found no
significant correlation between duration or severity of
illness and psychiatric symptomatology (anxiety, depres-
sion, eating disorders, or global emotional disturbance).
Britto et al. w7x found that there was no significant
association between physicalypsychosocial scores and
lung function or exercise tests. The relevance of this
finding to adults is questionable as the young adult sub-
group was combined with data from younger patients
for the analysis of QOL associations and predictors.
However, de Jong et al. w5x found that although QOL
scores were not significantly related to pulmonary func-
tion tests, maximal exercise capacity was negatively
correlated with overall and physical QOL impairment.
Furthermore, MRC dyspnoea (Medical Research Coun-
cil graded scale of limitation in function due to
dyspnoea) correlated highly with overall, physical and
psychosocial quality of life scores. Congleton et al. w6x
found there were correlations between the scores in
many of the dimensions (for example energy, sleep and
physical mobility) which assess perceived distressydis-
ability and clinical variables such as FEV % predicted,1
shortness of breath and time in hospital, but not body
mass index. Orenstein et al. w9x found that QOL scores,
measured using the Quality of Well-Being scale, were
significantly related to pulmonary function tests and
exercise performance, which is not surprising as the
QWB scale does emphasise physical functioning in
judging QOL. The QWB scale assesses recent health-
related limitation of mobility, physical activity and social
activity, and recent problematic symptoms.
There is evidence that acute changes in health do
have an effect on quality of life. Britto et al. w7x found
that an increasing number of pulmonary exacerbations
in the previous 6 months and a decreasing number of
days since the last exacerbation both had a detrimental
effect on a patient’s QOL. In a second study, Orenstein
et al. w10x also found improvements in overall QOL
(QWB scale) correlated with improvements of most
pulmonary function tests during treatment of an acute
pulmonary exacerbation in CF adolescents. Our experi-
ence at the Brompton is that mood deteriorates with
serious decline in physical health after a long period of
stability.
There is little research into the whether long-term
changes in health effect quality of life, either in terms
of a cohort of patients or the individual. A follow-up
study to Congleton et al. found poor correlation between
changes in physiological parameters and changes in
Nottingham Health Profile scores over a small number
of years (1–3) w11x. However, these patients were in a
relatively stable phase of the disease. There was a
significant correlation between changes in the energy
and physical mobility dimensions and change in a ‘CF-
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specific’ symptom-based total score over the years
studied.
One possible explanation of why there appears to be
little consistent correlation between somatic health meas-
ures and mental health measures is the discrepancy in
some patients between their subjective health perception
and their health as measured by clinical scales. Staab et
al. w12x found that although clinical medical scores,
hours spent daily on treatment and subjective health
perception all were important explanations of variance
in QOL in a group of 89 adult and adolescent patients,
subjective health perception was the strongest predictor.
Subjective health perception often differs from clinical
health as measured by physicians w13,14x.
The long-term adaptation and coping strategies
employed by cystic fibrosis patients may well also partly
explain the lack of association between quality of life
and disease severity—as the disease severity slowly
changes over the long-term the patient adapts, so their
QOL does not decline until the disease becomes so
severe they cannot adapt successfully. However, large
changes in the physical health over short time-periods
may lead to changes in the patient’s QOL before the
patients adapts. Change of disease severity, and rate of
change, rather than absolute disease severity, may well
be more likely to correlate to level of psychologicaly
psychosocial functioning. Therefore, longitudinal studies
of the psychologicalypsychosocial health of patients are
needed. Another explanation of the apparent lack of
correlation between psychologicalypsychosocial health
and disease severity may be that the variance in social
support may hide any relationship to disease severity.
Anderson et al. w1x did find that better psychosocial
support was a strong indicator of better psychological
functioning.
All these studies have used instruments designed for
general medical problems. One of the problems in
comparing studies is that they have all used different
analytical instruments. Several CF-specific QOL instru-
ments are being designed, for example Gee et al. w15x
which may be more sensitive in detecting changes in
the QOL of CF patients. However, standardising disease-
specific instruments may be difficult and there is the
danger in such instrument being overly-sensitive and
not weighting appropriately the issues which actually
affect the patients’ quality of life the most.
Finally, the variance in QOL amongst cystic fibrosis
patients is likely to be affected by many variables and,
therefore, finding a strong correlation between QOL and
any single variable, without accounting for other varia-
bles, would seem unlikely.
4. The effect of gender
Although older papers suggested that women were
more likely to suffer severe emotional disturbance than
men, the limited number of more recent papers do not
necessarily support this. In fact, Anderson et al. w1x
found that male gender was, if anything, a predictor of
psychiatric emotional disturbance. Men with CF may be
especially liable to suffer psychological distress in being
unable to fulfil the traditional male role of being the
provider w8x. The differences in the emotional problems
of the two sexes could partly be a result of how Anglo-
Saxon culture effects them.
Congleton et al. w6x reported that some of the dimen-
sions in which men and women suffered distressy
disability were shared (e.g. pain) and others different
(e.g. men in the dimension of energy, while for women
sleep). Similarly, the areas of daily living that the two
genders reported problems in were partly shared and
partly different. For men, there was an age-related trend
in several dimensions with perceived quality of life in
older men increasingly worse than scores in a healthy
population of the same age. There were no statistically
significant age-related trends in women.
Coping patterns also differ and this may effect long-
term health w16x. Female adolescents rely heavily on
denial. Males rely less heavily on denial but have more
behavioural problems. Males also appear to integrate
better having a physical disorder into their self-concept.
Female patients remain longer in hospital than male
patients even though their physical problems are no
more severe w16x.
Willis et al. w17x have suggested that the interaction
between the social identities of the two genders and
management of cystic fibrosis may be important in
explaining a body of evidence that there is a higher
morbidity and mortality for cystic fibrosis in females.
The feminine identity may invoke a more passive
approach to health and less investment in the future.
The masculine identity may encourage a more active
approach to health together with less cognitive pre-
occupation with the negative aspects of the disease upon
their lives. Furthermore, the social pressure of women
being slim may encourage poor nutrition in female
patients. Beneficial exercise may be promoted in male
patients by the social norm of a preoccupation with
sport and fitness in men, though not so in women.
However, data from our unit looking at morbidity and
mortality over the last 40 years show no gender
difference.
5. The effect of age
When considering the psychosocial functioning of
people of different ages it is difficult to distinguish
between the effect of ageing itself and the effects of the
changing prognosis, treatments and attitudes of different
patient cohorts, as outlook has improved.
Adolescent patients with cystic fibrosis may well
suffer emotional disturbance both as a result of the
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disease and the general emotional turbulence of adoles-
cence. One patient reflecting on his own experience w18x
commented that adolescents may be annoyed by constant
questioning of how they feel (reminding them of their
illness), and the lengthy daily treatment. There was a
danger of developing a defence mechanism of social
isolation to avoid distress from comparing themselves
to healthy peers. Adolescents may also be annoyed by
referral to paediatric centres w19x.
Older literature remarks that small stature and delayed
puberty may cause depression, poor body-image,
strained interpersonal relationships, increased awareness
of death and denial of sexuality w20,21x. There is little
modern literature on whether adolescent or adult patients
do now suffer psychological distress resulting from small
stature and delayed puberty—better treatment during
childhood and adolescence may well mean that these
are now less severe problems. The possibility of short
stature and delayed puberty should be explained to
teenagers with CF before they get worried about such
problems w22x.
Pearson et al. w2x found eating disorders to be more
common in children and young adolescents with CF
than in adults, although this may merely reflect the
natural history of eating disorders. A recent study found
no increase in eating disorders in CF adolescents when
compared to a control group w23x.
The transfer of a patient from a paediatric CF centre
to an adult centre is a time of great importance in the
treatment of the patient—it may generate anxiety in
patients and some may wish not to move from the
centre they are familiar with. Non-compliance may occur
w24x. Transfer is best done with joint sessions. Treatment
of young adults on paediatric wards sometimes engen-
ders the childish reaction of rebelliousness owing to the
less accommodating nature of paediatric wards w25x.
As patients get older and their disease more serious,
studies have found that their self-esteem declines, they
suffer from more discomfort with their social situation,
increased frustration and their compliance decreases.
Pearson et al. w2x found older patients to have a higher
prevalence of anxiety and depression but no significant
increase in global emotional disturbance, compared to
children. Blair et al. w3x found increased emotional
disturbance with increased age, which did not appear to
be the result of changing disease severity.
There are few papers dealing with CF in older adults
because it is only recently that survival into adulthood
has become common. Research is needed into the
psychological and psychosocial impact of CF upon older
adults and the research involving adolescents and young-
er adults needs to be repeated.
6. The effect of coping style
People with CF can be divided into copers and non-
copers. It is hard to define the cut-off between coping
and non-coping, and similarly between different coping
strategies. This leads to problems in comparing different
studies that have used different methods of classifying
coping.
Coping strategies can be subdivided into two
groups—attention responders and avoidance responders.
Avoidance may also be referred to as denial or minimi-
sation. Most research concludes that attention responders
may have a poorer psychological outcome than avoid-
ance responders w26x. Strauss and Wellisch w27x reported
‘prominent use of denial’ and ‘minimisation’ in cystic
fibrosis.
Staab et al. w12x found, using multiple regression
analyses, that ways of coping contributed significantly
to the overall variance in quality of life. Coping by
using (positive) social comparison correlated with a
higher quality of life while depressive coping was
negatively correlated with quality of life. There was a
weak correlation between cognitive avoidance and a
worse quality of life. This study also found that the
ways in which parents cope is an extremely important
factor in determining the quality of life of the parents
of children with cystic fibrosis (and possibly parents of
CF adults).
Those who cope with avoidance generally have a
worse compliance. Abbott et al. w28x found that patients
adherent to treatment plans used the coping strategies
of optimistic acceptance and hopefulness to a greater
extent than those who were non-adherent, while the
latter group of patients reported using avoidance strate-
gies to a greater extent.
There needs to be more research in the area of coping
styles. The question of which group has a better quality
of life is unanswered. There is little, if any, information
comparing the longer-term outlook (in terms of CF
severity and life expectancy) of the two coping styles.
Helping the patient achieve a beneficial coping strategy
may be just as important as other forms of treatment.
7. Daily life and platonic relationships (fitting into
society)
Many people with cystic fibrosis have problems with
interpersonal relationships (both platonic and non-pla-
tonic) resulting in isolation and social maladjustment
w29x. If relationships are not formed in teenage years
they may never be formed w19x.
Many people with CF experience problems with
independence, such as fear of moving away from home
w20x. A higher proportion of adults with CF than average
remain living in the parental home in adulthood, espe-
cially men w8x.
CF patients can suffer psychological problems of
embarrassment of their cough, sputum and offensive
stools when treatment is not working w30x.
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There is the anxiety that if their diagnosis is revealed,
then regardless of their current health they may be
refused employment w19x. Unemployment, which is not
uncommon in CF, may cause psychological problems.
The increasing survival of patients into adulthood, the
advent of new and often expensive treatments and the
lack of appreciation of CF as a disability mean that
economic strain is becoming an increasing problem for
CF patients although this differs greatly between
countries.
8. Sexuality and fertility
Problems in this area include body image, intimacy,
reduced fertility in both sexes, the hereditary nature of
the disease and the fear of dying before any children
that they have grow up w20,31,32x. Cystic fibrosis (per
se) does not produce sexual difficulty until it becomes
severe w33x. However, sexual problems have been found
to be frequent amongst people with CF. There is an
increased level of sexual dissatisfaction primarily among
unmarried people with CF w4x.
With the increasing survival of CF patients into
adulthood with reasonable health, making pregnancy
less dangerous, having children is becoming increasing
relevant. This is creating new possible psychological
problems for people with CF requiring education and
counselling w22x. Artificial insemination has been found
to improve fertility. Bilateral absence of the vasa defer-
entia occurs in most men with cystic fibrosis, causing
infertility. Although, donor sperm may circumvent male
infertility, the technique of intracytoplasmic sperm injec-
tion (ICSI), which could be combined with pre-implan-
tation genetic diagnosis if the partner is a carrier of a
mutated CF gene, can now allow CF men to father
children of their own w34x. However, this has the issues
of any new technique, especially in the field of fertility
studies, such as any adverse effects on health of progeny
of ICSI in which the natural physiological selection of
the fittest sperm does not occur w35x. Also there are
those concerns that anyone with CF will have when
considering having children, such as concerns of passing
the disease responsible genes to offspring and the high
possibility of being ill or dying during their progeny’s
childhood.
9. The family
Although studies in this area centre on children, as
adolescents and even, at times, adults with CF remain
within the family unit it is germane to discuss this here.
Mothers have often been found to be overly involved
and protective of the child with CF, while the fathers
help less often leading to the father’s withdrawal w36x.
Depression is common among mothers (approx. 30%),
but is far less common among the fathers w3,37x. In
1981, Bywater w37x noted that the majority of mothers
said they would welcome help dealing with these psy-
chological problems but had not been offered it. Siblings
(without CF) of children with CF have been observed
to be angry and resentful of the (comparative) lack of
parental attention and showed more school problems
w36x. This can lead to a family unit breakdown in areas
of communication, social isolation, decreased satisfac-
tion and poor adjustment w36x.
It is important to note that family coping affects the
health of the child with CF and possibly the health of
people with CF when they are older—better family
coping leads to better health of the child w36x. Such
family coping involves maintaining an integrated, coher-
ent family with good self-esteem. A decline in the health
of the child with CF has been found to lead to increased
family stress w36x.
10. Disease understanding and treatment
Inadequate knowledge and incorrect beliefs about CF
may be associated with psychological distress. There is
a disparity between perceived and actual health and
vulnerability. This indicates some uncertainty about the
effects of the disease andyor lack of understanding
about medical therapy w38x.
In adults there is a common misconception that they
are healthier than they are w14x, though this does not
mean that they may not overestimate some of the effects
of the disease and wrongly attribute problems to being
caused by their CF. This leads to normal problemsy
crises of life being wrongly attributed to having CF. It
is important to help patients express secret worries and
anxieties with counselling w39x. Adolescents and their
parents also often show a tendency for overestimation,
rather than under-estimation of the effects of the disease
w39x.
There are also possible psychological problems result-
ing from misunderstanding disease complications and
treatment, especially rarer complications w40x. Some
people with CF have problems dispelling irrational fears
such as the expectation of a sudden death w41x. Strange
physical complaints (e.g. somatic complaints not related
to physical parameters) may be of emotional meaning
w16x.
Transplants and transplant waiting lists can lead to
their own psychological problems. Patients suffer psy-
chological problems owing to ‘waiting’ on a transplant
list or being unsuitable for a transplant. One stress which
may be suffered by transplantees is that someone else
had to die for them to live w42x. A major reason for
psychiatric referral of CF patients is assessment for
suitability for transplant from a psychiatric perspective,
for example in terms of coping, possible psychiatric
problems and compliance. The new technique of lobe
transplants from live donors may cause new psycholog-
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ical problems, both for the CF patient and potential
donors. For example, both recipient and donors may
feel undue guilt and responsibility regarding any signif-
icant complications that might arise to the others
involved.
Large improvements in quality of life have been
shown following heart–lung transplantation in patients
with CF w43x. The sensitivity of QOL scales to more
minor CF treatments is uncertain. It is important that as
new treatments such as gene therapy become available
that before-and-after quality of life research is conduct-
ed, helping to assess the benefits of these treatments.
11. Non-compliance
There is a high-degree of non-compliance, with over
half of people with CF showing significant non-compli-
ance in at least one aspect of management w44x. Reasons
for non-compliance can be divided into general factors
that are not specific to particular treatments and factors
that are treatment-specific.
Non-compliance may be accidental or intentional.
Koocher et al. w45x divided reasons for non-compliance
into inadequate knowledge, psychosocial resistance
wstruggles for control, peer group concerns, avoidance
(coping style), despairx or educated non-adherence
(choice based on a full understanding of reasons and
results of followingynot following the treatment). How-
ever, the most common cause of non-compliance may
be forgetfulness w14x. It is important to acknowledge
that incomplete adherence is normal and not to take a
judgmental approach when dealing with the patient w46x.
Many patients underestimate the severity of their CF
especially as it deteriorates and they overestimate the
quality of their self-care w13x. Such misevaluation may
lead to the belief that compliance is not as important as
it is, leading to increased non-compliance. Poor knowl-
edge about treatment may also result in unintentional
poor compliance with treatment regimes w40x. Treatment
details are often misinterpreted; clear simple protocols
are needed w47x. Compliance may be improved by both
a better patient understanding of CF and the value of
compliance.
There is a problem with chronic diseases that patients
learn a lot about their disease and may disagree with
their doctors about their treatment. The ensuing struggle
for control may lead to non-compliance w25x. Non-
compliance in general may result when doctors expect
patients to submit to their authority and do not appear
responsive to patient’s beliefs and concerns, i.e. a bad
doctor–patient relationship can lead to non-compliance
w25x.
Non-compliance is often associated with a coping
mechanism of avoidance. Patients who have more out-
patient visits have been found to be more compliant
w14x.
Abbott et al. w48x have found that the greater the
level of worry regarding the disease, the more likely
they were to adhere to their physiotherapy, pancreatic
enzymes and vitamins but not exercise (which seems to
be perceived differently). They also found that (report-
ed) adherence to physiotherapy, exercise, pancreatic
enzymes and vitamins is not influenced by patient’s
perceptions of their past, current and future disease
severity or perceived susceptibility to recurrent infec-
tions, although other studies disagree with this. Percep-
tion of having little self-control over the disease has
also been linked to greater (reported) adherence (except
with exercise) w48x. If the level of perceived severity
becomes too great, denial may begin w48x.
Non-compliance may result when the patients find
that the demands of CF treatments have to be balanced
with those of other aspects of their lives, such as work,
relationships and family w14x. This is again intentional
non-compliance but of a more conscious, reasoned
nature. Those feeling in control may deliberately decide
not to comply because they perceive themselves to be
well and in control, balancing treatment with living a
normal life w48x. Non-compliance is more likely when
treatments are incompatible with the person’s goal of
normality w25x.
Compliance is generally worse in adulthood than
childhood and may be worse in women than men. The
time and commitment demands become more difficult
in adolescence and adult life which may in part help to
explain why compliance tends to decrease with age w14x.
Another reason is that children are forced to comply
with treatment by their parents. Problems of compliance
are particularly likely during adolescence (due to the
‘rebellious’ nature of adolescents) w24,49x. Adolescents
resent being helped by parents with physiotherapy, so
Forced Expiration Technique in conjunction with pos-
tural drainage is a useful method of physiotherapy.
Compliance is not influenced by demographic details,
nor intelligence w47x.
In many cases reasons for non-compliance are treat-
ment-specific and compliance may be improved by more
tailoring of treatment to a specific patient’s life-style
w14,44x. Compliance with vitamin treatment and physi-
otherapy is worse than with enzyme and exercise ther-
apies w44x. Example reasons for non-compliance with
particular treatments include w14x: embarrassment with
taking pancreatic enzymes; exercise was a preferred
alternative to physiotherapy; nebulised antibiotics and
inhaled steroids were found to taste awful. Physiother-
apy, dietary supplements and nebulised therapies require
the most planning and are most interfering with life
w14x. Physiotherapy was viewed as a large demand on
time and commitment, repetitive and onerous, and cou-
pled to the perception in some patients that it makes no
difference, results in non-compliance. Exercise allows
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social integration and compliance is therefore greater
w44,47x.
Compliance is extremely high with self-administered
intravenous antibiotics taken at home which improves
independence and causes less disruption and is therefore
preferred to inpatient infusion w50x.
Compliance is better when immediate and obvious
benefits are experienced w25,44,47x. Self monitoring of
respiratory function would be beneficial as it would
indicate the benefits of medications, convincing patients
that actions make a difference w14x.
Lask w46x lists several important approaches to man-
aging compliance: empathy (a warm, non-judgemental
approach, acknowledging that incomplete compliance is
normal); enthusiasm (communicating confidence and
hope); exploration (of the individual’s reasons for non-
compliance and problems with treatments allowing a
personalised treatment plan); education; and expression
of emotion. It is important to allow and aid the person
to express feelings such as sadness, anger, envy, fear,
frustration, resentment and depression. Management is
best when it is a therapeutic alliance between the patient
and medical staff, the latter being friendly, empathic,
supportive, non-critical and understanding w51x.
Small group interactive sessions may be beneficial in
cystic fibrosis, including managing poor compliance,
providing peer support and the knowledge that others
have had similar problems w14,52x.
12. Conclusion
Cystic fibrosis is an uncommon but deadly disease.
New treatments for cystic fibrosis are emerging includ-
ing lobe transplants from live donors, gene therapy and
new fertility treatments to allow males with CF to
become biological fathers. Although life expectancy has
increased, it is very important that we cater not just for
quantity but also quality of life. In addition, prognosis
is probably closely related to compliance which itself is
greatly affected by psychosocial factors.
The psychological and psychosocial functioning of
this group of patients appears to be relatively normal
but there are aspects in which they have significant
distress and disability. However, there is relatively little
research into the psychological well being of adults with
cystic fibrosis and with increasing numbers of patients
surviving into adulthood, more research is needed. Fur-
thermore, older studies are becoming increasing inappli-
cable as treatment and prognosis changes.
Research is needed to clarify whether mental health
problems are a significant factor in patients with cystic
fibrosis and if so whether they need treatment in their
own right and whether such treatment effects the prog-
nosis of the underlying medical condition. If poor mental
health is a significant factor then research is needed into
what are the predictors of significant mental health
problems and what preventative measures can be taken.
For example should routine psychological assessment
be carried out at regular intervals in cystic fibrosis and
should specialised psychiatric input be available to CF
units?
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